Moxifloxacine Krka

Moxifloxacin, the active ingredient in Moxifloxacine Krka, is a fluoroquinolone presented as an oral tablet for oral use. It treats a variety of bacterial infections in adult patients, including respiratory, skin and intra‑abdominal infections.

GNH USA supplies Moxifloxacine Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides reliable logistics for global distribution. Our network ensures timely delivery and regulatory support for each market.

Moxifloxacin is indicated for several bacterial infections affecting the respiratory, skin and abdominal systems.

Community‑acquired pneumonia: reduces bacterial load and improves clinical outcomes in adult patients. Acute bacterial sinusitis: eradicates the causative pathogens and relieves sinus inflammation. Acute exacerbations of chronic bronchitis: shortens symptom duration and prevents disease progression. Skin and soft tissue infections: eliminates susceptible organisms and promotes wound healing. Complicated intra‑abdominal infections: provides broad‑spectrum coverage for mixed aerobic and anaerobic bacteria.

Moxifloxacin may cause a range of adverse reactions, which are classified by frequency and severity.

Common Side Effects: - Nausea - Diarrhea - Headache - Dizziness - Abdominal pain - Rash

Serious or Rare Side Effects: - Tendon rupture or inflammation - QT interval prolongation leading to arrhythmia - Severe allergic reactions such as anaphylaxis - Clostridioides difficile‑associated colitis - Hepatic dysfunction - Peripheral neuropathy

When prescribing Moxifloxacine Krka, clinicians should observe several safety considerations.

Assess renal function: adjust therapy if renal impairment is present. Check for hypersensitivity: discontinue if an allergic reaction occurs. Monitor tendon health: advise patients to report tendon pain or swelling promptly. Evaluate cardiac risk: avoid use in patients with known QT prolongation. Store at room temperature: keep in the original packaging, protect from moisture and light.

Moxifloxacin can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Antacids containing magnesium or aluminum: markedly reduce oral absorption of moxifloxacin. - Warfarin: may increase anticoagulant effect and bleeding risk. - Theophylline: can raise serum theophylline concentrations, leading to toxicity.

Moderate Interactions (Monitor Closely): - Corticosteroids: combined use may increase risk of tendon rupture. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may enhance central nervous system stimulation.